ΒΙΟΖ’s and Embryolab’s approach is holistic and will be based on the analysis of the whole genome and not just on individual genes, and thus will shed light on the most complex genetic and mutation correlations which affect and determine male fertility. Therefore, participation in the programme will not only offer valuable assistance in producing the diagnostic test itself, but in terms of assisted reproduction, the new database, which will designed specifically for the Greek population, will permit a better understanding of hereditary mutations and consequently will be able to determine with precision the likelihood of offspring carrying the specific mutations. Furthermore, new scientific data will contribute both to a better understanding of the genetic basis of low fertility amongst men as well as to developing methods for diagnosing and treating it.